Dr. Reena Sharma MD , MBBS
Swastik Rheumatology Clinic
21 Years Experience
Professional Summary
Dr. Reena Sharma is a distinguished Rheumatologist based in Ahmedabad, Gujarat, with over 21 years of specialized experience in diagnosing and treating rheumatic diseases. As the founder of Swastik Rheumatology Clinic, Dr. Sharma is renowned for her compassionate, patient-centered approach to managing complex autoimmune and inflammatory conditions. Her expertise spans the full spectrum of rheumatological disorders, utilizing cutting-edge technology and evidence-based treatments to improve patients' quality of life.
Hospital Affiliations
Swastik Rheumatology Clinic (Founder & Director)
- Ahmedabad, Gujarat, India
Hospital Features:
- State-of-the-art rheumatology diagnostic facilities
- Advanced imaging and laboratory services
- Comprehensive autoimmune disease management center
- Patient education and support programs
Specialization Areas
Inflammatory Arthritis
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Juvenile Idiopathic Arthritis
- Reactive Arthritis
Autoimmune Connective Tissue Diseases
- Systemic Lupus Erythematosus
- Scleroderma
- Sjögren's Syndrome
- Mixed Connective Tissue Disease
Spondyloarthropathies
- Ankylosing Spondylitis
- Axial and Peripheral Spondyloarthritis
- Inflammatory Back Pain
Crystal Arthropathies
- Gout Management
- Pseudogout (CPPD)
- Hyperuricemia Treatment
Soft Tissue Rheumatism
- Fibromyalgia Care
- Myofascial Pain Syndrome
- Tendinitis and Bursitis
Treatment Philosophy
Dr. Sharma follows a comprehensive, patient-centered approach to rheumatological care:
Holistic Care Model:
- Thorough clinical assessment and history
- Personalized treatment plans
- Patient education and self-management support
- Long-term follow-up and support
Clinical Excellence:
- Evidence-based practice
- Multidisciplinary collaboration
- Advanced diagnostics
- Compassionate care
Advanced Diagnostic & Treatment Services
Comprehensive Rheumatological Assessment
- Joint examination and functional scoring
- Disease activity monitoring
- Quality of life evaluation
Advanced Laboratory Services
- Autoantibody profiling
- Inflammatory marker testing
- HLA typing
Therapeutic Interventions
- DMARDs and biologics
- Intra-articular steroid injections
- Immunosuppressive therapy
Support Programs
- Patient education workshops
- Exercise and physiotherapy coordination
- Nutritional counseling
Support Services
- CKD Education Workshops for rheumatic conditions
- Lifestyle modification and physiotherapy
- Psychological support and counseling
- Family education for hereditary conditions
Reopine Consultation Details
Available Services:
- First Opinion Consultations
- Second Opinion Reviews
- Autoimmune Disease Consultations
- Arthritis Management
- Medication Reviews
- Diagnostic Interpretation
Languages Spoken:
- English (Fluent)
- Hindi (Fluent)
- Gujarati (Fluent)
Book Your Consultation
Dr. Reena Sharma offers comprehensive rheumatology consultations through Reopine's virtual platform, providing expert guidance on autoimmune diseases, arthritis management, and chronic care.
Date: 05 Nov 2025
-
Nature of Services
- I understand that Reopine is a technology platform that connects me with independent, licensed doctors in India for medical opinion/teleconsultation.
- I acknowledge that Reopine itself does not provide medical services, diagnosis, or treatment. All medical advice is given solely by the consulting doctor.
-
Teleconsultation Limitations
- I understand that teleconsultation has inherent limitations compared to in-person consultation, including lack of physical examination and limited access to diagnostic tests.
- I agree that the medical opinion provided may be limited by the information, history, and documents I provide.
-
Emergency Situations
- I acknowledge that Reopine is not to be used in emergency or life-threatening situations.
- In case of emergencies, I shall immediately contact local healthcare providers or emergency numbers (e.g., 108 in India / 911 in USA).
-
Cross-Border Consultations
- I understand that all doctors on Reopine are licensed to practice in India only.
- If I access the platform from outside India:
- I agree that the consultation is deemed to have occurred in India under Indian law.
- I accept full responsibility for compliance with my country’s local laws.
- I waive any claim against Reopine in foreign jurisdictions.
- The information provided during this consultation is for general health guidance and educational purposes only.
- It is not a substitute for an in-person medical examination by a doctor licensed in your country.
- The doctor may offer advice or general treatment options based on information you share, but you are strongly advised to:
- Consult a locally licensed physician before starting or changing any medication or treatment.
- The consultation is conducted based on good faith, relying on the accuracy and completeness of the information you provide.
-
Data Privacy
- I consent to Reopine collecting, processing, and storing my personal and medical information in accordance with its Privacy Policy and applicable Indian data protection laws.
- I understand that my health records may be shared with consulting doctors for the purpose of the consultation.
-
Payment, Refund & Liability
- I understand that payments made are subject to Reopine’s Cancellation & Refund Policy.
- I agree that Reopine’s liability, if any, shall be limited to the amount of service fees paid by me for the disputed consultation, and not exceeding INR 10,000 in any case.
- I acknowledge that any malpractice or negligence claim lies against the individual doctor, not against Reopine.
-
Consent & Acknowledgment
By proceeding, I confirm that:
- I have read and understood the Terms & Conditions and this Consent Form.
- I voluntarily consent to teleconsultation via Reopine.
- I release Reopine from liability for outcomes beyond its control, including medical opinions of independent doctors, third-party technology failures, or my own failure to follow medical advice.
Patient’s Full Name:
Signature: ____________________________
Date: 05 Nov 2025
Subcribe to our Newsletter
Subscribe for Updates: Stay informed about the latest investor updates, financial results, and announcements by subscribing to our newsletter.